Metraipolis › archive › dc_ea72bac24ed5
Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without… — Europe PMC PMID:40579995
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40579995
- DOI
- 10.1093/neuonc/noaf156
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-09T16:22:50.398Z
- SHA-256 of the archived text
d98a2cdb0335d5a20141010dde4ea6e3cb5b35e898b4fee8a345ab3db2e79551- Stable URL of this page
https://metraipolis.com/documento/dc_ea72bac24ed5
How to cite
Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without… — Europe PMC PMID:40579995 — Europe PMC (en), https://europepmc.org/article/MED/40579995 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ea72bac24ed5 (Metraipolis archive dc_ea72bac24ed5, sha256 d98a2cdb0335d5a20141010dde4ea6e3cb5b35e898b4fee8a345ab3db2e79551)
BibTeX
@misc{dcea72bac24ed5,
title = {Final report on North Central Cancer Treatment Group N0877 (alliance): A phase II randomized, placebo-controlled trial of chemoradiotherapy with or without… — Europe PMC PMID:40579995},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40579995},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ea72bac24ed5; sha256 d98a2cdb0335d5a20141010dde4ea6e3cb5b35e898b4fee8a345ab3db2e79551},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40579995. Agents can read the archived copy with the MCP tool read_document.